Core Insights - The company is responding to the growing opportunities in the health industry driven by global demographic changes and increasing health awareness, particularly in China, where the aging population and digital technology are expanding the "silver economy" market [1][2] Group 1: Business Expansion Strategies - The company aims to enhance its health-related business by focusing on the development of a comprehensive health service ecosystem that covers prevention, diagnosis, medication, rehabilitation, and care [1] - A new subsidiary, Shenzhen Can Dong Health Technology Co., Ltd., has been established to create an intelligent health management platform utilizing General Artificial Intelligence (AGI) and digital technology for real-time health data monitoring [1] - The platform will integrate features such as dynamic health monitoring, risk assessment, personalized health interventions, and medication reminders, with plans to connect to medical institutions and home care services [1] Group 2: High-End Healthcare and Elderly Care Industry - The company is actively expanding its business in the high-quality healthcare and elderly care sector by forming strategic partnerships with various enterprises to explore opportunities in biomedicine, rehabilitation care, and health management [2] - A joint venture has been established in Anhui to leverage resources in research, production, and distribution, with expectations of generating positive cash flow by 2026 [2] Group 3: Health and Personal Care Product Trade - The company recognizes the significant growth potential in the health and personal care product market for the elderly and plans to enhance its e-commerce presence while establishing a comprehensive supply chain [2] - Initial cooperation agreements have been reached with suppliers from various regions, aiming to introduce a diverse range of personal health care products, with stable revenue expected by Q4 2025 [2] Group 4: Strategic Importance and Future Outlook - The business expansion is a strategic move based on market trends and the company's resource advantages, focusing on a dual-driven model of "technology + health" and "products + services" [3] - The company plans to increase investments in digitalization, AGI, and biotechnology to enhance its service capabilities and industry competitiveness, aiming to create long-term sustainable value for shareholders and investors [3]

Core Insights - The company is seizing unprecedented opportunities in the health industry driven by global demographic changes and rising health awareness, particularly in China, where the aging population and digital technology are expanding the "silver economy" market [1][3] - The company aims to build a comprehensive health service ecosystem covering prevention, diagnosis, medication, rehabilitation, and care, contributing significantly to its revenue [1] Group 1: Smart Health Management Platform - The company has established a wholly-owned subsidiary, Shenzhen Can Dong Health Technology Co., Ltd., and formed a research team focused on health data analysis and intelligent services [1] - The platform will integrate dynamic vital sign monitoring, intelligent risk assessment, personalized health interventions, and medication reminders, with plans to connect to medical institutions and home care scenarios [2] - The company plans to increase investment in general artificial intelligence and big data systems in the health sector over the next three years, expecting significant revenue growth once the platform is operational [2] Group 2: High-End Medical and Health Services - The company is expanding its business in the medical and health care sector to meet the growing demand for high-quality care, having signed strategic cooperation agreements with several enterprises [3] - A joint venture has been established in Anhui to explore the development of biomedicine, rehabilitation care, and health management in the Greater China region [3] - The joint venture is expected to generate positive cash flow for the company by 2026 [3] Group 3: Health and Personal Care Product Trade - The company is enhancing its channel and supply chain layout in the health and personal care product market, which is projected to grow significantly [4] - The company plans to strengthen its e-commerce presence and establish a comprehensive supply chain system covering both online and offline channels [4] - Initial cooperation agreements have been reached with suppliers from various regions, with expectations of stable revenue generation by Q4 2025 and market share growth in 2026 and 2027 [4] Group 4: Strategic Initiatives - The company's strategy focuses on integrating technology with health services and product offerings to create a complete business chain [4] - Continued investment in digitalization, general artificial intelligence, and biotechnology is planned to enhance service capabilities and industry competitiveness [4] - The company believes these initiatives will enrich its business structure and create long-term sustainable value for shareholders and investors [4]

Core Insights - The company is focusing on the health industry, particularly in response to the aging population and increasing health awareness, aiming to build a comprehensive health service ecosystem [1] Group 1: Smart Health Management Platform - The company has established a wholly-owned subsidiary to develop an intelligent health management platform utilizing AGI technology, focusing on health data analysis and smart services [2] - The platform will integrate features such as dynamic monitoring, risk assessment, personalized health interventions, and medication reminders, with plans to connect with healthcare institutions and home care services [2] - The company anticipates significant revenue growth from the platform once operational, aiming for a dual-driven profit model through technology output and service subscriptions [2] Group 2: High-end Healthcare and Elderly Care - The company is expanding its business in the high-quality healthcare and elderly care sector, having signed strategic cooperation agreements with several firms to explore biomedicine, rehabilitation, and health management [3] - The collaboration will leverage resources in R&D, production, and distribution, with a focus on promoting products in the Greater Bay Area and mainland cities [3] - The joint ventures are expected to generate positive cash flow for the company by 2026 [3] Group 3: Health and Personal Care Product Trade - The company aims to strengthen its trade in health and personal care products, recognizing the growing market potential in the elderly care sector [4] - It plans to enhance its e-commerce presence and establish a comprehensive supply chain covering both online and offline channels [4] - Initial cooperation agreements have been reached with suppliers from various regions, with expectations for stable revenue generation by Q4 2025 and market share growth in 2026 and 2027 [4] - The strategic initiative aims to create a complete business chain encompassing health management, elderly care services, and product trade, while increasing investment in digitalization and biotechnology [4]

香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內容概不 負 責，對 其 準 確 性 或 完 整 性 亦 不 發 表 任 何 聲 明，並 明 確 表 示，概 不 對 因 本 公 告 全部或任何部分內容而產生或因依賴該等內容而引致的任何損失承擔任何責 任。 AI Health Technology Limited 智慧健康科技有限公司 （於開曼群島註冊成立的有限公司） （股份代號：1715） (前稱 Volcano Spring International Holdings Limited 火山邑動國際控股有限公司) 自願公告 業務更新 本 公 告 由 智 慧 健 康 科 技 有 限 公 司（「本公司」，連 同 其 附 屬 公 司 統 稱「本集團」）自 願 作 出，旨 在 向 本 公 司 股 東（「股 東」）及 潛 在 投 資 者 提 供 本 集 團 最 新 業 務 發 展 之 更 新。 一、市場背景與戰略方向 3. 強 化 健 康 與 個 人 護 理 產 品 貿 易，完 善 渠 道 與 供 應 鏈 佈 局 伴 隨 全 球 人 口 結 構 變 化 與 健 康 意 識 提 升，大 健 康 產 業 正 迎 ...

FF301 股份發行人及根據《上市規則》第十九B章上市的香港預託證券發行人的證券變動月報表 截至月份: 2025年9月30日 狀態: 新提交 致：香港交易及結算所有限公司 公司名稱: 智慧健康科技有限公司 (於開曼群島註冊成立的有限公司) 呈交日期: 2025年10月2日 I. 法定/註冊股本變動 | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | | 於香港聯交所上市 (註1) | | | 是 | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 證券代號 (如上市) | 01715 | 說明 | | | | | | | | | | | 法定/註冊股份數目 | | | 面值 | | | 法定/註冊股本 | | | 上月底結存 | | | 600,000,000 | HKD | | 0.25 | HKD | | 150,000,000 | | 增加 / 減少 (-) | | | 0 | | | | HKD | | 0 | | 本月底結存 | | | 600,000,000 | HKD | | 0.25 | HKD | ...

AI Health Technology Limited 智慧健康科技有限公司 (Incorporated in the Cayman Islands with limited liability) ( 於開曼群島註册成立的有限公司 ) (Stock Code 股份代號: 1715) AI Health Technology Limited (the "Company") – Notice of publication of 2025 Interim Report (the "Current Corporate Communications") on the Company's website The Current Corporate Communications in both English and Chinese versions, are available on the website of the Company at www.aihealth-technology.com and the website of The Stock Exchange of Hong Kong Limited at ...

AI Health Technology Limited 智慧健康科技有限公司 (Incorporated in the Cayman Islands with limited liability) (於開曼群島註册成立的有限公司) (Stock Code 股份代號: 1715) NOTIFICATION LETTER 通知信函 Dear Registered Shareholder, AI Health Technology Limited (the "Company") – Notice of publication of 2025 Interim Report (the "Current Corporate Communications") on the Company's website The English and Chinese versions of the Company's Current Corporate Communications are available on the Company's website at www.aihealth- technology.com and t ...

AI Health Technology Limited 智慧健康科技有限公司 (股份代號：1715) (於開曼群島註冊成立的有限公司) (前稱火山邑動國際控股有限公司) 2025 2025 INTERIM REPORT 中期報告 AI Health Technology Limited 智慧健康科技有限公司 (Incorporated in the Cayman Islands with limited liability) (Formerly known as Volcano Spring International Holdings Limited) (Stock Code: 1715) 目錄 | 公司資料 | 02 | | --- | --- | | 業務回顧及未來前景 | 03 | | 管理層討論及分析 | 04 | | 簡明綜合中期全面收益表 | 11 | | 簡明綜合中期財務狀況表 | 13 | | 簡明綜合中期權益變動表 | 15 | | 簡明綜合中期現金流量表 | 16 | | 簡明綜合中期財務資料附註 | 17 | | 其他資料 | 24 | 2025年中期報告 智慧健康科技有限公司 02 ...

香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內容概不 負 責，對 其 準 確 性 或 完 整 性 亦 不 發 表 任 何 聲 明，並 明 確 表 示，概 不 對 因 本 公 告 全部或任何部分內容而產生或因依賴該等內容而引致的任何損失承擔任何責 任。 AI Health Technology Limited 智慧健康科技有限公司 （於開曼群島註冊成立的有限公司） (前稱 Volcano Spring International Holdings Limited 火山邑動國際控股有限公司) （股份代號：1715） (I)於二零二五年九月三日舉行的 股 東 特 別 大 會 的 投 票 表 決 結 果；及 (II)股本削減及股份拆細的最新進展 茲 提 述 智 慧 健 康 科 技 有 限 公 司（「本公司」）日 期 為 二 零 二 五 年 八 月 十 五 日 的 通 函 （「通 函」）及 本 公 司 股 東 特 別 大 會 通 告（「通 告」）。除 文 義 另 有 所 指 外，本 公 告 所 界 定 的 詞 彙 與 通 函 所 界 定 者 具 有 相 同 涵 義。 (I) 股東特別大會的投票表決結果 本 ...

FF301 股份發行人及根據《上市規則》第十九B章上市的香港預託證券發行人的證券變動月報表 截至月份: 2025年8月31日 狀態: 新提交 致：香港交易及結算所有限公司 公司名稱: 智慧健康科技有限公司 (於開曼群島註冊成立的有限公司) 呈交日期: 2025年9月1日 I. 法定/註冊股本變動 | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | | 於香港聯交所上市 (註1) | | 是 | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 證券代號 (如上市) | 01715 | 說明 | | | | | | | | | | 法定/註冊股份數目 | | | 面值 | | 法定/註冊股本 | | | 上月底結存 | | | 600,000,000 | HKD | | 0.25 HKD | | 150,000,000 | | 增加 / 減少 (-) | | | 0 | | | HKD | | 0 | | 本月底結存 | | | 600,000,000 | HKD | | 0.25 HKD | | 150,000,000 | 本月底 ...